How Food Companies Are Capitalizing on Weight-Loss Drugs

Estimated reading time: 3 minutes

A New Opportunity

This year saw the rise of powerful new weight loss drugs such as Novo Nordisk’s (NVO) Ozempic and Wegovy. But food companies are seeing an opportunity.

These new drugs work by suppressing appetites, which has left many investors bearish on food suppliers as more Americans begin taking these drugs. However, savvy food companies have begun marketing their products as either an alternative to weight-loss drugs, or as a supplement to be consumed alongside them.

Food Companies Capitalize

These new drugs cause people to lose muscle mass, not just fat. Now, Nestlé has announced products designed to combat that exact issue, which could launch as soon as next year. General Mills (GIS) and Abbott Laboratories (ABT), maker of Ensure protein shakes, have announced similar plans.

Prepared for Change

Food suppliers are confident in their ability to adapt to consumer trends, and with the drugs still in their infancy, there’s plenty of time to adjust or pivot.

The extent to which these drugs will be used long-term, and how they will affect the food industry, remains to be seen.

Disclaimer
SoFi Securities (Hong Kong) Limited and its affiliates (SoFi HK) may post or share information and materials from time to time. They should not be regarded as an offer, solicitation, invitation, investment advice, recommendation to buy, sell or otherwise deal with any investment instrument or product in any jurisdictions. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
SoFi HK does not make any warranties about the completeness, reliability and accuracy of this information and will not be liable for any losses and/or damages in connection with the use of this information.
The information and materials may contain hyperlinks to other websites, we are not responsible for the content of any linked sites. The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi HK. These links are provided for informational purposes and should not be viewed as an endorsement. The risk involved in using such hyperlinks shall be borne by the visitor and subject to any Terms of Use applicable to such access and use.
Any product, logos, brands, and other trademarks or images featured are the property of their respective trademark holders. These trademark holders are not affiliated with SoFi HK or its Affiliates. These trademark holders do not sponsor or endorse SoFi HK or any of its articles.
Without prior written approval of SoFi HK, the information/materials shall not be amended, duplicated, photocopied, transmitted, circulated, distributed or published in any manner, or be used for commercial or public purposes.